Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 01, 2019

SELL
$0.65 - $2.12 $3.42 Million - $11.2 Million
-5,259,868 Closed
0 $0
Q4 2018

Feb 07, 2019

BUY
$1.22 - $2.41 $2.2 Million - $4.34 Million
1,800,000 Added 52.03%
5,259,868 $8.42 Million
Q2 2018

Aug 01, 2018

BUY
$2.75 - $3.85 $2.05 Million - $2.87 Million
744,706 Added 27.43%
3,459,868 $9.52 Million
Q1 2018

May 14, 2018

BUY
$3.5 - $4.47 $214,210 - $273,577
61,203 Added 2.31%
2,715,162 $9.5 Million
Q4 2017

Feb 13, 2018

BUY
$3.29 - $5.03 $8.73 Million - $13.3 Million
2,653,959
2,653,959 $11.3 Million

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Menora Mivtachim Holdings Ltd. Portfolio

Follow Menora Mivtachim Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menora Mivtachim Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Menora Mivtachim Holdings Ltd. with notifications on news.